0.3133
price up icon2.69%   0.0082
 
loading
Schlusskurs vom Vortag:
$0.3051
Offen:
$0.3021
24-Stunden-Volumen:
451.72K
Relative Volume:
0.48
Marktkapitalisierung:
$29.06M
Einnahmen:
$147.75M
Nettoeinkommen (Verlust:
$-284.23M
KGV:
-0.1069
EPS:
-2.93
Netto-Cashflow:
$-317.54M
1W Leistung:
+8.94%
1M Leistung:
+7.59%
6M Leistung:
-8.42%
1J Leistung:
-73.67%
1-Tages-Spanne:
Value
$0.3021
$0.3228
1-Wochen-Bereich:
Value
$0.28
$0.3228
52-Wochen-Spanne:
Value
$0.18
$1.53

Fibrogen Inc Stock (FGEN) Company Profile

Name
Firmenname
Fibrogen Inc
Name
Telefon
415-978-1200
Name
Adresse
350 BAY STREET, SAN FRANCISCO, CA
Name
Mitarbeiter
225
Name
Twitter
@FibroGenInc
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
FGEN's Discussions on Twitter

Vergleichen Sie FGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FGEN
Fibrogen Inc
0.3133 29.06M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-08 Herabstufung BofA Securities Neutral → Underperform
2023-06-26 Herabstufung BofA Securities Buy → Neutral
2023-06-26 Herabstufung Raymond James Outperform → Mkt Perform
2023-06-26 Herabstufung Stifel Buy → Hold
2023-06-26 Herabstufung William Blair Outperform → Mkt Perform
2023-06-02 Hochstufung Stifel Hold → Buy
2023-01-31 Hochstufung William Blair Mkt Perform → Outperform
2023-01-26 Hochstufung Raymond James Mkt Perform → Outperform
2023-01-05 Hochstufung BofA Securities Neutral → Buy
2021-09-22 Herabstufung Goldman Neutral → Sell
2021-08-20 Hochstufung Raymond James Underperform → Mkt Perform
2021-07-16 Herabstufung BofA Securities Buy → Neutral
2021-07-16 Herabstufung Stifel Buy → Hold
2021-04-07 Herabstufung H.C. Wainwright Buy → Neutral
2021-04-07 Herabstufung Mizuho Buy → Neutral
2021-03-31 Hochstufung BofA Securities Neutral → Buy
2021-03-02 Herabstufung Jefferies Buy → Hold
2021-02-01 Eingeleitet H.C. Wainwright Buy
2020-10-26 Eingeleitet Raymond James Underperform
2020-07-10 Fortgesetzt Stifel Buy
2020-05-01 Eingeleitet Cowen Market Perform
2020-04-27 Eingeleitet BofA/Merrill Neutral
2019-05-29 Fortgesetzt Goldman Neutral
2019-05-10 Herabstufung William Blair Outperform → Mkt Perform
2019-04-12 Eingeleitet Piper Jaffray Neutral
2019-02-11 Fortgesetzt Stifel Buy
2018-12-19 Hochstufung Citigroup Neutral → Buy
2017-08-08 Bestätigt Leerink Partners Outperform
2017-08-08 Bestätigt Stifel Buy
2017-07-21 Herabstufung Goldman Buy → Neutral
2017-07-11 Eingeleitet Jefferies Buy
2016-02-11 Hochstufung Credit Suisse Neutral → Outperform
2016-01-21 Eingeleitet Credit Suisse Neutral
2015-12-04 Eingeleitet Citigroup Buy
2015-09-23 Eingeleitet Lake Street Hold
2015-07-29 Eingeleitet Citigroup Buy
2015-07-20 Hochstufung Goldman Neutral → Buy
2014-12-09 Eingeleitet Stifel Buy
Alle ansehen

Fibrogen Inc Aktie (FGEN) Neueste Nachrichten

pulisher
May 19, 2025

FibroGen, Inc. (NASDAQ:FGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 17, 2025

FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline - MSN

May 17, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

FibroGen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Has Negative Outlook for FibroGen Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

FibroGen’s Earnings Call: Strategic Gains Amid Revenue Woes - TipRanks

May 15, 2025
pulisher
May 15, 2025

FibroGen (NASDAQ:FGEN) Earns Buy Rating from HC Wainwright - Defense World

May 15, 2025
pulisher
May 14, 2025

FibroGen (FGEN) Boosts Sale Proceeds from Chinese Division - GuruFocus

May 14, 2025
pulisher
May 13, 2025

FibroGen (FGEN) Receives Reaffirmed Buy Rating from HC Wainwrigh - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen, Inc. (NASDAQ:FGEN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc earnings beat by $0.15, revenue fell short of estimates - Investing.com UK

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

FibroGen (FGEN) Receives Reaffirmed Buy Rating from HC Wainwright & Co. | FGEN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid Revenue Decline - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen Reports Q1 2025 Earnings and Strategic Updates - TipRanks

May 13, 2025
pulisher
May 12, 2025

Earnings call transcript: FibroGen Q1 2025 sees revenue drop, stock rises - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

FibroGen Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimates at $2.7M, EPS Misses with $0.16 Loss - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimat - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025
pulisher
May 12, 2025

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025
pulisher
May 12, 2025

FIBROGEN INC SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 11, 2025

StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - Defense World

May 11, 2025
pulisher
May 10, 2025

FibroGen (FGEN) Set to Release Q1 Earnings Results - GuruFocus

May 10, 2025
pulisher
May 06, 2025

FibroGen to Report First Quarter 2025 Financial Results - The Manila Times

May 06, 2025
pulisher
May 05, 2025

FibroGen Q1 2025 Earnings Call: Key Details for May 12 Financial Results Release - Stock Titan

May 05, 2025
pulisher
May 05, 2025

FibroGen, Inc. to Announce Q1 2025 Financial Results and Host Conference Call on May 12 - Nasdaq

May 05, 2025
pulisher
May 03, 2025

FibroGen (FGEN) to Release Quarterly Earnings on Monday - Defense World

May 03, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 01, 2025

FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

May 01, 2025
pulisher
Apr 27, 2025

Investor Network: FibroGen, Inc. to Host Earnings Call - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Sells 97,900 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

FGEN Stock Price and Chart — NASDAQ:FGEN - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

Investors Don't See Light At End Of FibroGen, Inc.'s (NASDAQ:FGEN) Tunnel And Push Stock Down 26% - simplywall.st

Apr 08, 2025
pulisher
Apr 04, 2025

Q1 Earnings Estimate for FibroGen Issued By William Blair - Defense World

Apr 04, 2025

Finanzdaten der Fibrogen Inc-Aktie (FGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Fibrogen Inc-Aktie (FGEN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722
Adib Deyaa
Chief Medical Officer
Jun 12 '24
Buy
1.17
22,123
25,884
82,123
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):